BSX – Boston Scientific Corporation
Float Short %
1.35
Margin Of Safety %
10
Put/Call OI Ratio
0.57
EPS Next Q Diff
0.05
EPS Last/This Y
0.52
EPS This/Next Y
0.44
Price
91.3
Target Price
125.16
Analyst Recom
1.24
Performance Q
-8.62
Relative Volume
1.22
Beta
0.67
Ticker: BSX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | BSX | 96.07 | 0.79 | 0.34 | 213465 |
| 2025-12-29 | BSX | 95.79 | 0.79 | 1.28 | 212284 |
| 2025-12-30 | BSX | 96 | 0.79 | 4.46 | 215056 |
| 2025-12-31 | BSX | 95.38 | 0.82 | 1.23 | 219734 |
| 2026-01-02 | BSX | 94.72 | 0.82 | 2.82 | 220067 |
| 2026-01-05 | BSX | 95.5 | 0.86 | 0.96 | 225351 |
| 2026-01-06 | BSX | 97.76 | 0.86 | 0.37 | 228854 |
| 2026-01-07 | BSX | 98.66 | 0.85 | 0.29 | 231723 |
| 2026-01-08 | BSX | 98.39 | 0.84 | 0.49 | 234618 |
| 2026-01-09 | BSX | 97.63 | 0.84 | 4.20 | 236720 |
| 2026-01-12 | BSX | 95.7 | 0.92 | 0.83 | 241798 |
| 2026-01-13 | BSX | 94.08 | 0.92 | 1.01 | 245604 |
| 2026-01-14 | BSX | 93.74 | 0.91 | 1.32 | 246028 |
| 2026-01-15 | BSX | 89.99 | 0.93 | 3.13 | 251019 |
| 2026-01-16 | BSX | 87.87 | 0.96 | 0.88 | 264923 |
| 2026-01-20 | BSX | 91.19 | 1.10 | 0.08 | 203273 |
| 2026-01-21 | BSX | 91.71 | 0.56 | 0.61 | 316268 |
| 2026-01-22 | BSX | 91.28 | 0.57 | 0.78 | 327047 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | BSX | 96.08 | 11.6 | 2751.9 | 3.03 |
| 2025-12-29 | BSX | 95.76 | 11.6 | 2736.8 | 3.03 |
| 2025-12-30 | BSX | 96.01 | 11.6 | 2770.7 | 3.03 |
| 2025-12-31 | BSX | 95.38 | 11.6 | 2715.9 | 3.03 |
| 2026-01-02 | BSX | 94.71 | 11.6 | 2715.3 | 3.03 |
| 2026-01-05 | BSX | 95.50 | 11.6 | 2804.3 | 3.03 |
| 2026-01-06 | BSX | 97.79 | 11.6 | 2898.0 | 3.03 |
| 2026-01-07 | BSX | 98.66 | 11.6 | 2807.7 | 3.03 |
| 2026-01-08 | BSX | 98.37 | 11.6 | 2738.1 | 3.03 |
| 2026-01-09 | BSX | 97.62 | 11.6 | 2709.2 | 3.03 |
| 2026-01-12 | BSX | 95.69 | 11.6 | 2637.0 | 3.03 |
| 2026-01-13 | BSX | 94.09 | 11.6 | 2654.3 | 3.03 |
| 2026-01-14 | BSX | 93.72 | 11.6 | 2728.6 | 3.03 |
| 2026-01-15 | BSX | 89.99 | 11.6 | 2518.7 | 3.03 |
| 2026-01-16 | BSX | 88.07 | 11.6 | 2626.8 | 3.03 |
| 2026-01-20 | BSX | 91.18 | 11.6 | 2962.9 | 3.03 |
| 2026-01-21 | BSX | 91.71 | 11.6 | 2787.9 | 3.03 |
| 2026-01-22 | BSX | 91.30 | 11.6 | 2728.6 | 3.03 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | BSX | -5.20 | 0.41 | 1.30 |
| 2025-12-29 | BSX | -5.20 | 0.41 | 1.30 |
| 2025-12-30 | BSX | -5.20 | 0.41 | 1.30 |
| 2025-12-31 | BSX | -5.20 | 0.41 | 1.30 |
| 2026-01-02 | BSX | -5.20 | 0.41 | 1.30 |
| 2026-01-05 | BSX | -4.42 | 0.44 | 1.30 |
| 2026-01-06 | BSX | -4.42 | 0.44 | 1.30 |
| 2026-01-07 | BSX | -4.42 | 0.44 | 1.30 |
| 2026-01-08 | BSX | -4.42 | 0.44 | 1.30 |
| 2026-01-09 | BSX | -4.42 | 0.44 | 1.30 |
| 2026-01-12 | BSX | -4.39 | 0.39 | 1.30 |
| 2026-01-13 | BSX | -4.42 | 0.39 | 1.36 |
| 2026-01-14 | BSX | -4.42 | 0.39 | 1.36 |
| 2026-01-15 | BSX | -4.42 | 0.39 | 1.36 |
| 2026-01-16 | BSX | -4.42 | 0.39 | 1.36 |
| 2026-01-20 | BSX | -4.42 | 0.42 | 1.35 |
| 2026-01-21 | BSX | -4.42 | 0.42 | 1.35 |
| 2026-01-22 | BSX | -4.42 | 0.42 | 1.35 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.75
Avg. EPS Est. Current Quarter
0.78
Avg. EPS Est. Next Quarter
0.8
Insider Transactions
-4.42
Institutional Transactions
0.42
Beta
0.67
Average Sales Estimate Current Quarter
5289
Average Sales Estimate Next Quarter
5202
Fair Value
100.33
Quality Score
89
Growth Score
98
Sentiment Score
50
Actual DrawDown %
16.6
Max Drawdown 5-Year %
-25.2
Target Price
125.16
P/E
48.83
Forward P/E
26.27
PEG
1.61
P/S
7
P/B
5.78
P/Free Cash Flow
35.4
EPS
1.87
Average EPS Est. Cur. Y
3.03
EPS Next Y. (Est.)
3.47
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
14.43
Relative Volume
1.22
Return on Equity vs Sector %
-15.3
Return on Equity vs Industry %
-5.8
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
2728.6
Boston Scientific CorporationSector: Healthcare
Industry: Medical Devices
Employees: 53000
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
stock quote shares BSX – Boston Scientific Corporation Stock Price stock today
news today BSX – Boston Scientific Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BSX – Boston Scientific Corporation yahoo finance google finance
stock history BSX – Boston Scientific Corporation invest stock market
stock prices BSX premarket after hours
ticker BSX fair value insiders trading